New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 17, 2012
07:45 EDTVIVOMeridian Bioscience price target raised to $24 from $22 at RW Baird
Baird raised its price target on Meridian Bioscience following meeting with management. The firm believes investors sentiment is low but feels comfortable with guidance and management strategy for growth. Shares are Outperform rated.
News For VIVO From The Last 14 Days
Check below for free stories on VIVO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VIVO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use